Business Standard

Biogen Pharmachem Industries reports standalone net loss of Rs 1.59 crore in the June 2022 quarter

Image

Capital Market

Reported sales nil

Net loss of Biogen Pharmachem Industries reported to Rs 1.59 crore in the quarter ended June 2022 as against net profit of Rs 0.20 crore during the previous quarter ended June 2021. There were no Sales reported in the quarter ended June 2022 as against Rs 1.25 crore during the previous quarter ended June 2021. ParticularsQuarter EndedJun. 2022Jun. 2021% Var.Sales01.25 -100 OPM %016.00 -PBDT-1.590.20 PL PBT-1.590.20 PL NP-1.590.20 PL

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 03 2022 | 3:47 PM IST

Explore News